Zhangzhou Pientzehuang Pharmaceutical | 600436 - Operating Expenses


Zz Pientze Pharmaceu reported CNY1.88B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.01M 175K Mar/2026
Avita Medical AUD 28.02M 1.55M Dec/2025
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Dianthus Therapeutics USD 47M 22.83M Mar/2026
Ionis Pharmaceuticals USD 364M 54M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Jiangsu Hengrui CNY 5.52B 604.29M Mar/2026
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Moderna USD 1.78B 242M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Sh Fosun Pharma CNY 9.18B 2.12B Mar/2026
Tectonic Therapeutic USD 27.3M 5.78M Mar/2026
Viatris USD 3.54B 323.9M Mar/2026
Wuxi Apptec CNY 7.33B 511.69M Mar/2026
Xeris Pharmaceuticals USD 75.21M 6.18M Mar/2026
Zz Pientze Pharmaceu CNY 1.88B 326.34M Mar/2026